Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Deloitte
Novartis
Covington
Healthtrust
US Department of Justice
Cantor Fitzgerald
Queensland Health
Argus Health

Generated: February 20, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,605,897

« Back to Dashboard

Summary for Patent: 5,605,897
Title: 2-methyl-thieno-benzodiazepine
Abstract:Olanzapine, or an acid salt thereof, has pharmaceutical properties, and is of particular use in the treatment of disorders of the central nervous system. The compound has the following structure: ##STR1##
Inventor(s): Beasley, Jr.; Charles M. (Indianapolis, IN), Chakrabarti; Jiban K. (Camberley, GB2), Hotten; Terrence M. (Farnborough, GB2), Tupper; David E. (Reading, GB2)
Assignee: Eli Lilly and Company (Indianapolis, IN) Lilly Industries Limited (Basingstoke)
Application Number:08/387,498
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 5,605,897

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents Family Members for US Patent 5,605,897

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 127804 ➤ Try a Free Trial
Australia 643267 ➤ Try a Free Trial
Australia 7518691 ➤ Try a Free Trial
Bulgaria 61710 ➤ Try a Free Trial
Canada 2041113 ➤ Try a Free Trial
China 1028429 ➤ Try a Free Trial
China 1056693 ➤ Try a Free Trial
Czechoslovakia 9101168 ➤ Try a Free Trial
Cyprus 1900 ➤ Try a Free Trial
Czech Republic 279937 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Argus Health
Citi
Deloitte
Merck
Julphar
Cantor Fitzgerald
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot